Could you tell me about the firm? Mr. Kennedy: AllSource is a firm that focuses on high-net-worth and ultra-high-net-worth families, and we specialize in alternative investments. We like to say we ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

Caprock Group LLC purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 3,344 ...

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

It was a busy week for the biotech sector as the fourth-quarter earnings season kicked in. While Regeneron REGN gained following the announcement, Amgen AMGN was in the red. Meanwhile, other pipeline ...

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, ...

Bio-Techne Corporation (TECH) stock climbs as its Q2 FY25 results exceed Wall Street estimates amid recovery in the biopharma end market. Read more here.